» Articles » PMID: 31862442

A Multistage Sequencing Strategy Pinpoints Novel Candidate Alleles for Emery-Dreifuss Muscular Dystrophy and Supports Gene Misregulation As Its Pathomechanism

Abstract

Background: As genome-wide approaches prove difficult with genetically heterogeneous orphan diseases, we developed a new approach to identify candidate genes. We applied this to Emery-Dreifuss muscular dystrophy (EDMD), characterised by early onset contractures, slowly progressive muscular wasting, and life-threatening heart conduction disturbances with wide intra- and inter-familial clinical variability. Roughly half of EDMD patients are linked to six genes encoding nuclear envelope proteins, but the disease mechanism remains unclear because the affected proteins function in both cell mechanics and genome regulation.

Methods: A primer library was generated to test for mutations in 301 genes from four categories: (I) all known EDMD-linked genes; (II) genes mutated in related muscular dystrophies; (III) candidates generated by exome sequencing in five families; (IV) functional candidates - other muscle nuclear envelope proteins functioning in mechanical/genome processes affected in EDMD. This was used to sequence 56 unlinked patients with EDMD-like phenotype.

Findings: Twenty-one patients could be clearly assigned: 18 with mutations in genes of similar muscular dystrophies; 3 with previously missed mutations in EDMD-linked genes. The other categories yielded novel candidate genes, most encoding nuclear envelope proteins with functions in gene regulation.

Interpretation: Our multi-pronged approach identified new disease alleles and many new candidate EDMD genes. Their known functions strongly argue the EDMD pathomechanism is from altered gene regulation and mechanotransduction due to connectivity of candidates from the nuclear envelope to the plasma membrane. This approach highlights the value of testing for related diseases using primer libraries and may be applied for other genetically heterogeneous orphan diseases.

Funding: The Wellcome Trust, Muscular Dystrophy UK, Medical Research Council, European Community's Seventh Framework Programme "Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS)".

Citing Articles

Amphipathic helices sense the inner nuclear membrane environment through lipid packing defects.

Lee S, Le Roux A, Mors M, Vanni S, Roca-Cusachs P, Bahmanyar S bioRxiv. 2024; .

PMID: 39605395 PMC: 11601446. DOI: 10.1101/2024.11.14.623600.


Meta-analysis towards FSHD reveals misregulation of neuromuscular junction, nuclear envelope, and spliceosome.

Schatzl T, Todorow V, Kaiser L, Weinschrott H, Schoser B, Deigner H Commun Biol. 2024; 7(1):640.

PMID: 38796645 PMC: 11127974. DOI: 10.1038/s42003-024-06325-z.


Variants Cause Atrioventricular Node Dysfunction and Arrhythmogenic Changes in Cardiac Electrophysiology and Intracellular Calcium Handling in Zebrafish.

Stoyek M, Doane S, Dallaire S, Long Z, Ramia J, Cassidy-Nolan D Genes (Basel). 2024; 15(3).

PMID: 38540339 PMC: 10969970. DOI: 10.3390/genes15030280.


Native lamin A/C proteomes and novel partners from heart and skeletal muscle in a mouse chronic inflammation model of human frailty.

Elzamzami F, Samal A, Arun A, Dharmaraj T, Prasad N, Rendon-Jonguitud A Front Cell Dev Biol. 2023; 11:1240285.

PMID: 37936983 PMC: 10626543. DOI: 10.3389/fcell.2023.1240285.


Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies.

Rawls A, Diviak B, Smith C, Severson G, Acosta S, Wilson-Rawls J Biomolecules. 2023; 13(10).

PMID: 37892218 PMC: 10605463. DOI: 10.3390/biom13101536.


References
1.
Flanigan K, von Niederhausern A, Dunn D, Alder J, Mendell J, Weiss R . Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet. 2003; 72(4):931-9. PMC: 1180355. DOI: 10.1086/374176. View

2.
Norwood F, Harling C, Chinnery P, Eagle M, Bushby K, Straub V . Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009; 132(Pt 11):3175-86. PMC: 4038491. DOI: 10.1093/brain/awp236. View

3.
Gueneau L, Bertrand A, Jais J, Salih M, Stojkovic T, Wehnert M . Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet. 2009; 85(3):338-53. PMC: 2771595. DOI: 10.1016/j.ajhg.2009.07.015. View

4.
Rowat A, Lammerding J, Ipsen J . Mechanical properties of the cell nucleus and the effect of emerin deficiency. Biophys J. 2006; 91(12):4649-64. PMC: 1779937. DOI: 10.1529/biophysj.106.086454. View

5.
Bonne G, Mercuri E, Muchir A, Urtizberea A, Becane H, Recan D . Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol. 2000; 48(2):170-80. View